VCA Inc  

(Public, NASDAQ:WOOF)   Watch this stock  
Find more results for WOOF
40.58
+2.30 (6.01%)
After Hours: 40.58 0.00 (0.00%)
Oct 21, 5:08PM EDT  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 38.66 - 40.74
52 week 26.84 - 42.14
Open 38.66
Vol / Avg. 1.38M/773,718.00
Mkt cap 3.30B
P/E 25.09
Div/yield     -
EPS 1.62
Shares 86.21M
Beta 1.12
Inst. own 95%
Oct 23, 2014
Q3 2014 VCA Inc Earnings Call - 4:30PM EDT - Add to calendar
Oct 23, 2014
Q3 2014 VCA Inc Earnings Release - 4:00PM EDT - Add to calendar
Sep 9, 2014
VCA Inc at CL King & Associates Inc Best Ideas Conference
Jul 24, 2014
Q2 2014 VCA Inc Earnings Call - Webcast
Jul 24, 2014
Q2 2014 VCA Antech, Inc. Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin 9.58% 7.93%
Operating margin 16.32% 13.81%
EBITD margin - 18.24%
Return on average assets 8.35% 6.60%
Return on average equity 13.64% 11.04%
Employees 11,100 -
CDP Score - -

Address

12401 WEST OLYMPIC BOULEVARD
LOS ANGELES, CA 90064-1022
United States - Map
+1-310-5716500 (Phone)
+1-310-5716700 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

VCA Inc, formerly VCA Antech, Inc., is a national animal healthcare company operating in the United States and Canada. The Company provides veterinary services and diagnostic testing to support veterinary cares. The Company operates in two segments: animal hospital and laboratory. Its all other category includes Vetstreet and Medical Technology operating segments. The Company sells diagnostic imaging equipment and other medical technology products and related services to the veterinary markets. The Company's animal hospitals offer a range of general medical and surgical services for companion animals, as well as specialized treatments, including advanced diagnostic services, internal medicine, oncology, ophthalmology, dermatology and cardiology. In August 2014, VCA, Inc acquired Camp Bow Wow.

Officers and directors

Robert L. Antin Chairman of the Board, President, Chief Executive Officer
Age: 64
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Tomas W. Fuller Chief Financial Officer, Vice President, Principal Accounting Officer, Secretary
Age: 56
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Josh Drake President - Antech Diagnostics
Age: 46
Bio & Compensation  - Reuters
Arthur J. Antin Chief Operating Officer, Senior Vice President
Age: 67
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Neil Tauber Senior Vice President - Development
Age: 63
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
John M. Baumer Independent Director
Age: 46
Bio & Compensation  - Reuters
John B. Chickering Jr. Independent Director
Age: 65
Bio & Compensation  - Reuters
John A. Heil Independent Director
Age: 61
Bio & Compensation  - Reuters
Frank Reddick Independent Director
Age: 61
Bio & Compensation  - Reuters